Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL5091777 | 0.98 | FDPS (0.33) | FDPSDNM1 | |
| Bromide SCHEMBL5086993 | 0.98 | FDPS (0.33) | FDPSDNM1 | |
| Hydrochloric Acid SCHEMBL5091443 | 0.98 | FDPS (0.33) | FDPSDNM1 | |
| SCHEMBL2834536 | 0.95 | FDPS (0.36) | FDPSDNM1 | |
| SCHEMBL3305198 | 0.95 | — | — | |
| SCHEMBL3303129 | 0.93 | FDPS (0.37) | FDPSDNM1 | |
| SCHEMBL3307508 | 0.93 | FDPS (0.37) | FDPSDNM1 | |
| Hydrochloric Acid SCHEMBL1977248 | 0.93 | FDPS (0.35) | FDPSDNM1 | |
| Bromide SCHEMBL3043996 | 0.93 | FDPS (0.35) | FDPSDNM1 | |
| Iodide SCHEMBL5086927 | 0.93 | FDPS (0.35) | FDPSDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3383442-B1 | USE OF (HETERO)POLYOXOMETALATES FOR SIMULTANEOUSLY IMPARTING ANTIMICROBIAL PROPERTIES TO, AND REDUCING THE GROWTH OF A BIOFILM ON A SURFACE OF A SUBSTRATE IN OR ON A HOME APPLIANCE | BSH HAUSGERAETE GMBH (DE) | 2023-06-21 | — | — | EP | disclosed |
| US-11123721-B2 | Trialkylphosphonium ionic liquids, methods of making, and alkylation processes using trialkylphosphonium ionic liquids | UOP LLC (US) | 2021-09-21 | — | — | US | disclosed |
| CN-107848283-B | Anisotropic conductive film and display device using the same | 国都化学(株) | 2021-04-13 | — | — | CN | disclosed |
| EP-3459423-B1 | HOUSEHOLD APPLIANCE WITH AN ANCHORED POLYOXOMETALATE CONTAINING COMPONENT PART, PROCESS FOR THE MANUFACTURE OF AN ANCHORED POLYOXOMETALATE AND PROCESSES FOR THE MANUFACTURE OF THE COMPONENT PART | BSH HAUSGERAETE GMBH (DE) | 2020-08-26 | — | — | EP | disclosed |
| US-20190105644-A1 | TRIALKYLPHOSPHONIUM IONIC LIQUIDS, METHODS OF MAKING, AND ALKYLATION PROCESSES USING TRIALKYLPHOSPHONIUM IONIC LIQUIDS | CYTEC INDUSTRIES INC. | 2019-04-11 | — | — | US | disclosed |
| EP-3464304-A1 | TRIALKYLPHOSPHONIUM IONIC LIQUIDS, METHODS OF MAKING, AND ALKYLATION PROCESSES USING TRIALKYLPHOSPHONIUM IONIC LIQUIDS | UOP LLC (US) | 2019-04-10 | — | — | EP | disclosed |
| EP-3459423-A1 | HOUSEHOLD APPLIANCE WITH AN ANCHORED POLYOXOMETALATE CONTAINING COMPONENT PART, PROCESS FOR THE MANUFACTURE OF AN ANCHORED POLYOXOMETALATE AND PROCESSES FOR THE MANUFACTURE OF THE COMPONENT PART | BSH Hausgeräte GmbH (DE) | 2019-03-27 | — | — | EP | disclosed |
| EP-3383442-A2 | USE OF (HETERO)POLYOXOMETALATES FOR SIMULTANEOUSLY IMPARTING ANTIMICROBIAL PROPERTIES TO, AND REDUCING THE GROWTH OF A BIOFILM ON A SURFACE OF A SUBSTRATE IN OR ON A HOME APPLIANCE | BSH Hausgeräte GmbH (DE) | 2018-10-10 | — | — | EP | disclosed |
| EP-3383443-A1 | USE OF (HETERO)POLYOXOMETALATES FOR SIMULTANEOUSLY IMPARTING ANTIMICROBIAL PROPERTIES TO A SURFACE OF A SUBSTRATE AND REDUCING THE GROWTH OF A BIOFILM ON THE SURFACE OF THE SUBSTRATE | POM Patentverwaltungs GbR (DE) | 2018-10-10 | — | — | EP | disclosed |
| US-9914674-B2 | Process for alkylation using low ionic liquid volume fraction | UOP LLC (US) | 2018-03-13 | — | — | US | disclosed |
| WO-2014122225-A1 | HETEROPOLYOXOMETALATES | ITICON GMBH (DE) | 2014-08-14 | — | — | WO | disclosed |
| US-8673489-B2 | Nonaqueous electrolytic solution and nonaqeuous-electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| WO-2014004232-A1 | ALKYLATION PROCESS USING PHOSPHONIUM-BASED IONIC LIQUIDS | UOP LLC (US) | 2014-01-03 | — | — | WO | disclosed |
| EP-2166611-B1 | NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE | MITSUBISHI CHEM CORP (JP) | 2013-12-25 | — | — | EP | disclosed |
| US-20130280622-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-10-24 | — | — | US | disclosed |
| EP-2535976-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-20120308881-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQEUOUS-ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120264010-A1 | NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-10-18 | — | — | US | disclosed |
| US-20100099031-A1 | NONAQUEOUS ELECTROLYTES AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERIES EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2166611-A1 | NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH THE NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2010-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11123721-B2 | Trialkylphosphonium ionic liquids, methods of making, and alkylation processes using trialkylphosphonium ionic liquids | IP6K3, IP6K1, IP6K2 | FDPS 1011/4885DNM1 4843/4885 |
| US-20190105644-A1 | TRIALKYLPHOSPHONIUM IONIC LIQUIDS, METHODS OF MAKING, AND ALKYLATION PROCESSES USING TRIALKYLPHOSPHONIUM IONIC LIQUIDS | IP6K3, IP6K1, IP6K2 | FDPS 1011/4885DNM1 4843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.